Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine

Phytotherapy Research

Volumn 22, Issue 8, 2008, Pages 999-1012

  Imanshahidi, Mohsen ^a   Hosseinzadeh, Hossein ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Barberry; Berberine; Berberis vulgaris

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; BERBERINE; BERBERIS VULGARIS EXTRACT; CYCLOSPORIN A; METRONIDAZOLE; PLANT EXTRACT; PYRIMETHAMINE; SULFACETAMIDE; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL INFECTION; BERBERIS; BERBERIS VULGARIS; BLOOD PRESSURE; BRAIN INFARCTION; CARDIOVASCULAR EFFECT; CENTRAL NERVOUS SYSTEM FUNCTION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CYTOTOXICITY; DIARRHEA; DRUG EFFECT; DRUG USE; DYSLIPIDEMIA; DYSPNEA; ENDOCRINE SYSTEM; FEVER; FLU LIKE SYNDROME; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT FUNCTION; HEART ARRHYTHMIA; HEART INJURY; HUMAN; HYPERTENSION; IMMUNOMODULATION; INOTROPISM; LOW BACK PAIN; MALARIA; NONHUMAN; PENIS ERECTION; PROTECTION; RESPIRATORY FUNCTION; REVIEW; RHEUMATIC DISEASE; SIDE EFFECT; SKIN FUNCTION; THERAPY EFFECT; TOXICOLOGY;

BERBERINE; BERBERIS; HUMANS; IRAN; MEDICINE, TRADITIONAL; PHYTOTHERAPY; PLANTS, MEDICINAL;

BERBERIDACEAE; BERBERIS; BERBERIS VULGARIS;

EID: 50149108987     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2399     Document Type: Review

References (144)

1. Abidi P, Zhou Y, Jiang J.D, Liu J. 2005. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler Thromb Vasc Biol 25: 2170-2176.
2. Amin AH, Subbaiah TV, Abbasi KM. 1969. Berberine sulfate: antimicrobial activity, bioassay, and mode of action. Can J Microbiol 15: 1067-1076.
3. Anonymous. 2000. Berberine. Altern Med Rev 5: 175-177.
4. Awouters F, Niemegeers CJE, Lenaerts FM, Janssen PAJ. 1978. Delay of castor oil diarrhoea in rats: a new way to evaluate inhibitors of prostaglandin biosynthesis. J Pharm Pharmacol 30: 41-45.
5. Berlin G, Enerback L. 1983. Fluorescent berberine binding as a marker of secretory activity in mast cells. Int Arch Allergy Appl Immunol 71: 332-339.
6. Birdsall TC, Kelly GS. 1997. Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev 2: 94-103.
7. Cao JW, Luo HS, Yu BP, Huang XD, Sheng ZX, Yu JP. 2001. Effects of berberine on intracellular free calcium in smooth muscle cells of guinea pig colon. Digestion 64: 179-183.
8. Castillo J, Hung J, Rodriguez M, Bastidas E, Laboren I, Jaimes A. 2005. LED fluorescence spectroscopy for direct determination of monoamine oxidase B inactivation. Anal Biochem 343: 293-298.
9. Cernakova M, Kost'alova D, Kettmann V, Plodova M, Toth J, Drimal J. 2002. Potential antimutagenic activity of berberine, a constituent of Mahonia aquifolium. Complement Altern Med 2: 2.
10. Chan E. 1993. Displacement of bilirubin from albumin by berberine. Biol Neonate 63: 201-208.
11. Chiou WF, Chen J, Chen CF. 1998. Relaxation of corpus cavernosum and raised intracavernous pressure by berberine in rabbit. Br J Pharmacol 125: 1677-1684.
12. Chiou WF, Yen MH, Chen CF. 1991. Mechanism of vasodilatory effect of berberine in rat mesenteric artery. Eur J Pharmacol 204: 35-40.
13. Chun YT, Yip TT, Lau KL, Kong YC, Sankawa U. 1979. A biochemical study on the hypotensive effect of berberine in rats. Gen Pharmacol 10: 177-182.
14. Chung JG, Chen GW, Hung CF et al. 2000. Effects of berberine on arylamine N-acetyltransferase activity and 2-aminofluorene-DNA adduct formation in human leukemia cells. Am J Chin Med 28: 227-238.
15. Chung JG, Wu LT, Chu CB et al. 1999. Effects of berberine on arylamine N-acetyltransferase activity in human bladder tumour cells. Food Chem Toxicol 37: 319-326.
16. Cicero Arrigo FG, Rovati Lucio C, Setnikar Ivo. 2007. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation. Arzneimittelforschung 57: 26-30.
17. Ckless K, Schlottfeldt J, Pasqual M, Moyna P, Henriques J, Wajner M. 1995. Inhibition of in vitro lymphocyte transformation by the isoquinoline alkaloid berberine. J Pharm Pharmacol 47: 1029-1031.
18. Creasey WA. 1979. Biochemical effects of berberine. Biochem Pharm 28: 1081-1084.
19. DerMaderosian A. 2001. The Review of Natural Products. Facts and Comparisons: St. Louis, Missouri.
20. Drewesa SE, George J, Khan F. 2003. Recent findings on natural products with erectile-dysfunction activity. Phytochemistry 62: 1019-1025.
21. Dutta NK, Marker PH, Rao NR. 1972. Berberine in toxin induced experimental cholera. Br J Pharmacol 44: 153-159.
22. Fatehi-Hassanabad Z, Jafarzadeh M, Tarhini A, Fatehi M. 2005. The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats. Phytother Res 19: 222-225.
23. Feng CL, Liu SX, Feng QY, Yin JJ, Zhao L. 1996. A comparative study of antiplatelet aggregation by berberine hydrochloride with low dose aspirin. Shandong Med 36: 11-12.
24. Freile ML, Giannini F, Pucci G et al. 2003. Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla. Fitoterapia 74: 702-705.
25. Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. 1999. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol 66: 227-233.
26. Geng DS, Liu F, Liu XB, Yang YX. 1996. Effects of berberine sulphate on immune system. Chin Pharmacol Bull 12: 536-539.
27. Ghosh AK, Bhattacharya FK, Ghosh DK. 1985. Leishmania donovani: Amastigote inhibition and mode of action of berberine. Exp Parasitol 60: 404-413.
28. Han Y, Lee JH. 2005. Berberine synergy with amphotericin B against disseminated candidiasis in mice. Biol Pharm Bull 28: 541-544.
29. Hobara N, Watanabe A. 1984. Berberine-induced bile bilirubin secretion in the rat. Curr Ther Res Clin Exp 35: 663-667.
30. Hong Y, Hui SC, Chan TY, Hou JY. 2002. Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats. Am J Chin Med 30: 589-599.
31. Hong Y, Hui SS, Chan BT, Hou J. 2003. Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy. Life Sci 72: 2499-2507.
32. Hsiang CY, Wu SL, Cheng SE, Ho TY. 2005. Acetaldehyde-induced interleukin-1beta and tumor necrosis factor-alpha production is inhibited by berberine through nuclear factor-kappaB signaling pathway in HepG2 cells. J Biomed Sci 12: 791-801.
33. Huang CG, Chu ZL, Wei SJ, Jiang H, Jiao BH. 2002. Effects of berberine on arachidonic acid metabolism in rabbit platelets and endothelial cells. Thromb Res 106: 223-227.
34. Huang CG, Chu ZL, Yang ZM. 1991a. Effects of berberine on cytoplasmic cAMP and calcium influx of rabbit platelets. Acad J Sec Mil Med Univ 12: 320-322.
35. Huang CG, Chu ZL, Yang ZM. 1991b. The progress in pharmacological researches on berberine. Commun Inform Pharm 9: 10-12.
36. Hui KK, Yu JL, Chan WF, Tse E. 1991. Interaction of berberine with human platelet alpha 2 adrenoceptors. Life Sci 49: 315-324.
37. Hwang JM, Wang CJ, Chou FP et al. 2002. Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver. Arch Toxicol 76: 664-670.
38. lizuka N, Miyamoto K, Hazama S et al. 2000a. Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6. Cancer Lett 158: 35-41.
39. lizuka N, Miyamoto K, Okita K et al. 2000b. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Lett 148: 19-25.
40. Inbaraj JJ, Kukielczak BM, Bilski P, Sandvik SL, Chignell CF. 2001. Photochemistry and photocytotoxicity of alkaloids from Goldenseal (Hydrastis canadensis L.) 1. Berberine. Chem Res Toxicol 14: 1529-1534.
41. Ivanovska N, Philipov S. 1996. Study of the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol 18: 553-561.
42. Janbaz KH, Gilani AH. 2000. Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents. Fitoterapia 71: 25-33.
43. Kaneda Y, Torii M, Tanaka T, Aikawa M. 1991. In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. Ann Trop Med Parasitol 85: 417-425.
44. Kang DG, Sohn EJ, Kwon EK, Han JH, Oh H, Lee HS. 2003. Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels. Vasc Pharmacol 39: 281-286.
45. Kettmann V, Kosfalova D, Jantova S, Cernakova M, Drimal J. 2004. In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines. Pharmazie 59: 548-551.
46. Khosla PK, Neeraj VI, Gupta SK, Satpathy G. 1992. Berberine, a potential drug for trachoma. Rev Int Trach Pathol Ocul Trop 69: 147-165.
47. Kim DK, Lee KT, Baek Nl et al. 2004. Acetylcholinesterase inhibitors from the aerial parts of Corydalis speciosa. Arch Pharm Res 27: 1127-1131.
48. Ko BS, Choi SB, Park SK, Jang JS, Kim YE, Park S. 2005. Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma. Biol Pharm Bull 28: 1431-1437.
49. Ko WH, Yao XQ, Lau CW et al. 2000. Vasorelaxant and antiproliferative effects of berberine. Eur J Pharmacol 399: 187-196.
50. Kong LD, Cheng CHK, Tan RX. 2001. Monoamine oxidase inhibitors from rhizoma of Coptis chinensis. Planta Med 67: 74-76.
51. Kong W, Wei J, Abidi P et al. 2004. Berberine is a novel cholesterol lowering drug working through a unique mechanism distinct from statins. Nat Med 10: 1344-1351.
52. Kostalova D, Bukovsky M, Koscova H, Kardosova A. 2001. Anticomplement activity of Mahonia aquifolium bisben-zylisoquinoline alkaloids and berberine extract. Ceska Slov Farm 50: 286-289.
53. Kuo CL, Chi CW, Liu TY. 2004. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203: 127-137.
54. Kuo CL, Chi CW, Liu TY. 2005. Modulation of apoptosis by berberine through inhibition of cyclooxygenase-2 and Mcl-1 expression in oral cancer cells. In Vivo 19: 247-252.
55. Kuo CL, Choa CC, Yung BY. 1995. Berberine complexes with DNA in the berberine-induced apoptosis in human leukemia HL-60 cells. Cancer Lett 93: 193-200.
56. Küpeli E, Koşar M, Yeşilada E, Hüsnü K, Başer C. 2002. A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species. Life Sci 72: 645-657.
57. Lee HS. 2002. Rat lens aldose reductase inhibitory activities of Coptis japonica root-derived isoquinoline alkaloids. J Agric Food Chem 50: 7013-7016.
58. Lee MK, Kim El, Hur JD, Lee KS, Ro JS. 2001. Effects of protoberberine compounds on serotonin content in P815 cells. Korean J Pharmacogn 32: 49-54.
59. Lee CJ, Lee JH, Seok JH et al. 2003. Effects of baicalein, berberine, curcumin and hesperidin on mucin release from airway goblet cells. Planta Med 69: 523-526.
60. Lee S, Lim HJ, Park HY, Lee KS, Park JH, Jang Y. 2006. Berberine inhibits rat vascular smooth muscle cell proliferation and migration in vitro and improves neointima formation after balloon injury in vivo berberine improves neointima formation in a rat model. Atherosclerosis 186: 29-37.
61. Li TK, Bathory E, LaVoie EJ et al. 2000. Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug-enzyme interactions. Biochemistry 39: 7107-7116.
62. Li H, Miyahara T, Tezuka Y et al. 1999. The effect of kampo formulae on bone resorption in vitro and in vivo. II. Detailed study of berberine. Biol Pharm Bull 22: 391-396.
63. Li H, Miyahara T, Tezuka Y, Tran QL, Seto H, Kadota S. 2003. Effect of berberine on bone mineral density in SAMP6 as a senile osteoporosis model. Biol Pharm Bull 26: 110-111.
64. Li XT, Wang YL. 1997. Effect of berberine on cytosolic free calcium of rat myocardial cells in vitro. Yao Xue Xue Bao 32: 721-725.
65. Li BX, Yang BF, Zhou J, Xu CQ, Li YR. 2001. Inhibitory effects of berberine on IK1, IK, and HERG channels of cardiac myocytes. Acta Pharmacol Sin 22: 125-131.
66. Lin JG, Chung JG, Wu LT, Chen GW, Chang HL, Wang TF. 1999b. Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. Am J Chin Med 27: 265-275.
67. Lin HL, Liu TY, Wu CW, Chi CW. 1999a. Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel. Br J Cancer 81: 416-422.
68. Lin CC, Ng LT, Hsu FF, Shieh DE, Chiang LC. 2004a. Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth. Clin Exp Pharmacol Physiol 31: 65-69.
69. Lin S, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG. 2004b. Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol Pharmacol 66: 612-619.
70. Lin SS, Chung JG, Lin JP et al. 2005. Berberine inhibits arylamine N-acetyltransferase activity and gene expression in mouse leukemia L 1210 cells. Phytomedicine 12: 351-358.
71. Mahady GB, Pendland SL, Stoia A, Chadwick LR. 2003. In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from sanguinaria canadensis and Hydrastis Canadensis. Phytother Res 17: 217-221.
72. Marin-Neto JA, Maciel BC, Secches AL, Gallo L. 1988. Cardiovascular effects of berberine in patients with severe congestive heart failure. Clin Cardiol 11: 253-260.
73. Marinova EK, Nikolova DB, Popova DN, Gallacher GB, Ivanovska ND. 2000. Suppression of experimental autoimmune tubulointerstitial nephritis in BALBrc mice by berberine. Immunopharmacology 48: 9-16.
74. Mazzini S, Bellucci MC, Mondelli R. 2003. Mode of binding of the cytotoxic alkaloid berberine with the double helix oligonucleotide D(AAGAATTCTT). Bioorg Med Chem 11: 505-514.
75. Musumeci R, Speciale A, Costanzo R et al. 2003. Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin. Int J Antimicrob Agents 22: 48-53.
76. Namba T, Sekiya K, Toshinai A et al. 1995. Study on baths with crude drug. 2. The effects of coptidis rhizoma extracts as skin permeation enhancer. Yakugaku Zasshi 115: 618-625.
77. Nassiri-Asl M, Hosseinzadeh H, Mortazavi SR. 2007. Effects of Berberis vulgaris fruit extracts and its active component, berberine, on morphine dependence, hypnosis and locomotor activity in mice. Pharmacotogyonline 1: 190-202.
78. Ni XH, Zeng YY, Di JF et al. 2003. The effect of recipient kidney function by Ber coadministration CsA used to induce immune tolerance in rats of allogenic cardiac transplantation. Chin Pharmacol Bull 19: 1188-1190.
79. Oh KB, Oh MN, Kim JG, Shin DS, Shin J. 2006. Inhibition of sortase-mediated Staphylococcus aureus adhesion to fibronectin via fibronectin-binding protein by sortase inhibitors. Appl Microbiol Biotechnol 70: 102-106.
80. Olmez E, llhan M. 1992. Evaluation of the alpha-adrenoceptor antagonistic action of berberine in isolated organs. Arzneimittelforschung 42: 1095-1097.
81. Orfila L, Rodriguez M, Colman T, Hasegawa M, Merentes E, Arvelo F. 2000. Structural modification of berberine alkaloids in relation to cytotoxic activity in vitro. J Ethnopharmacol 71. 449-456.
82. Pan GY, Huang ZJ, Wang GJ et al. 2003. The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med 69: 632-636.
83. Pan GY, Wang GJ, Liu XD, Fawcett JP, Xie YY. 2002. The involvement of P-glycoprotein in berberine absorption. Pharmacol Toxicol 91: 193-197.
84. Peng WH, Hsieh MT, Wu CR. 1997. Effect of long-term administration of berberine on scopolamine-induced amnesia in rats. Jpn J Pharmacol 74: 261-266.
85. Peng WH, Wu CR, Chen CS, Chen CF, Leu ZC, Hsieh MT. 2004. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: Interaction with drugs acting at 5-HT receptors. Life Sci 75: 2451-2462.
86. Peychev L. 2005. Pharmacological investigation on the cardiovascular effects of Berberis vulgaris on tested animals. Pharmacia 52: 118-121.
87. Rabbani GH. 1996. Mechanism and treatment of diarrhoea due to Vibrio cholerae and Escherichia coli: roles of drugs and prostaglandins. Dan Med Bull 43: 173-185.
88. Rabbani GH, Butler T, Knight J, Sanyal SC, Alam K. 1987. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae. J Infect Dis 155: 979-984.
89. Ren LH, Vasil'ev AV, Orkehov AN, Tertov VV, Tutel'ian VA. 1989. Evaluation of the antiatherosclerotic properties of natural compounds of plant origin on cell cultures of the human aortic intima. Farmakol Toksikol 52: 44-46.
90. Sack RB, Froehlich JL. 1982. Berberine inhibits intestinal secretory response of Vibrio cholerae and Escherichia coli enterotoxins. Infect Immunol 35: 471-475.
91. Seki T, Morohashi M. 1993. Effect of some alkaloids, flavonoids and triterpenoids, contents of Japanese-Chinese traditional herbal medicines, on the lipogenesis of sebaceous glands. Skin Pharmacol 6: 56-60.
92. Sethi ML. 1983. Enzyme inhibition VI: inhibition of reverse transcriptase activity by protoberberine alkaloids and structure-activity relationship. J Pharm Sci 72: 538-541.
93. Shamsa F, Ahmadiani A, Khosrokhavar R. 1999. Antihistaminc and anticholinergic activity of barberry fruit (Berberis vulgaris) in the guinea-pig ileum. J Ethnopharmacol 64: 161-166.
94. Sheng WD, Jiddawi MS, Hong XQ, Abdulla SM. 1997. Treatment of chloroquine-resistant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole. East Afr Med J 74: 283-284.
95. Shin JS, Kim El, Kai M, Lee MK. 2000. Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem Res 25: 363-368.
96. Soffar SA, Metwali DM, Abdel-Aziz SS, el-Wakil HS, Saad GA. 2001. Evaluation of the effect of a plant alkaloid (berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro. J Egypt Soc Parasitol 31: 893-904.
97. Stermitz FR, Beeson TD, Mueller PJ, Hsiang JF, Lewis K. 2001. Staphylococcus aureus MDR efflux pump inhibitors from a Berberis and a Mahonia (sensu strictu) species. Biochem Syst Ecol 29: 793-798.
98. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K. 2000. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc Natl Acad Sci 97: 1433-1437.
99. Sun D, Abraham SN, Beachey EH. 1988a. Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli. Antimicrob Agents Chemother 32: 1274-1277.
100. Sun D, Courtney HS, Beachey EH. 1988b. Berberine sulfate blocks adherence of Streptococcus pyogenes to epithelial cells, fibronectin, and hexadecane. Antimicrob Agents Chemother 32: 1370-1374.
101. Swabb EA, Tai YH, Jordan L. 1981. Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine. Am J Physiol 241: G248-G252.
102. Tan Y, Ming Z, Tang Q, Jiang Z, Hu B, Xiang J. 2005. Effect of berberine on the mRNA expression of nitric oxide synthase (NOS) in rat corpus cavernosum. J Huazhong Univ Sci Technol Med Sci 25: 127-130.
103. Tan Y, Tang Q, Hu B, Xiang J. 2004. Effect of berberine on the mRNA expression of phosphodiesterase type 5 (PDE5) in rat corpus cavernosum. Zhonghua Nan Ke Xue 10: 890-893.
104. Tan YZ, Wu AC, Tan BY et al. 2002. Study on the interactions of berberine displace other drug from their plasma proteins binding sites. Chin Pharmacol Bull 18: 576-578.
105. Tanabe H, Suzuki H, Mizukami H, Inoue M. 2005. Double blockade of cell cycle progression by coptisine in vascular smooth muscle cells. Biochem Pharmacol 70: 1176-1184.
106. Taylor CT, Baird AW. 1993. Berberine inhibits electrogenic chloride secretion in rat colon. Br J Pharmacol 116: 2667-2672.
107. Taylor CT, Winter DC, Skelly MM et al. 1999. Berberine inhibits ion transport in human colonic epithelia. Eur J Pharmacol 368: 111-118.
108. Tsai CS, Ochillo RF. 1991. Pharmacological effects of berberine on the longitudinal muscle of the guinea-pig isolated ileum. Arch Int Pharmacodyn Trier 310: 116-131.
109. Vlietinck AJ, Bruyne TD, Apers S, Pieters LA. 1998. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta Med 64: 97-109.
110. Vrzal R, Zdarilova A, Ulrichova J, Blaha L, Giesy JP, Dvorak Z. 2005. Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: Biphasic effect on CYP1A1. Biochem Pharmacol 70: 925-936.
111. Wang CL, He SX, Wei F. 1993. A clinical investigation of berberine on treatment of 42 cases with hypertension. Med J Intern Mong 13: 54.
112. Wang YX, Yao XJ, Tan YH. 1994. Effects of berberine on delayed afterdepolarizations in ventricular muscles in vitro and in vivo. J Cardiovasc Pharmacol 23: 716-722.
113. Wang F, Zhao G, Cheng L, Zhou, HY, Fu LY, Yao WX. 2004a. Effects of berberine on potassium currents in acutely isolated CA1 pyramidal neurons of rat hippocampus. Brain Res 999: 91-97.
114. Wang YX, Zheng YM. 1997. Ionic mechanism responsible for prolongation of cardiac action-potential duration by berberine. J Cardiovasc Pharmacol 30: 214-222.
115. Wang F, Zhou HY, Zhao G et al. 2004b. Inhibitory effects of berberine on ion channels of rat hepatocytes. World J Gastroenterol 10: 2842-2845.
116. Wartenberg M, Budde P, De Marees M et al. 2003. Inhibition of tumor-induced angiogenesis and matrix-metalloproteinase expression in confrontation cultures of embryoid bodies and tumor spheroids by plant ingredients used in traditional Chinese medicine. Lab Invest 83: 87-98.
117. Whiteley CG, Daya S. 1995. Protein ligand interactions. Part 5: Isoquinoline alkaloids as inhibitors of acetylcholinesterase from Electrophorus electricus. J Enzyme Inhib 9: 285-294.
118. Wong KK. 1998. Mechanism of the aortic relaxation induced by low concentrations of berberine. Planta Med 64: 756-757.
119. Wu HL, Hsu CY, Liu WH, Yung BY. 1999a. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity. Int J Cancer 81: 923-929.
120. Wu X, Li Q, Xin H, Yu A, Zhong M. 2005. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol 61: 567-572.
121. Wu JF, Liu TP. 1995. Effects of berberine on platelet aggregation and plasma levels of TXB2 and 6-keto-PGF1 alpha in rats with reversible middle cerebral artery occlusion. Yao Xue Xue Bao 30: 98-102.
122. Wu J, Liu S, Pan X. 1999b. Protective effects of berberine on cultured central neuronal injuries induced by oxidative stress. Chin Pharm J 34: 525-529.
123. Wu JF, Liu TP, Wang JX, Yang SJ. 1997a. Effect of berberine on intracellular free CA2+ concentration in cultured brain cells. Yao Xue Xue Bao 32: 15-18.
124. 2+ elevation in isolated brain cells of neonatal rat. Chin J Pharmacol Toxicol 11: 7-10.
125. Wu SN, Yu HS, Jan CR, Li HF, Yu CL. 1998. Inhibitory effects of berberine on voltage- and calcium-activated potassium currents in human myeloma cells. Life Sci 62: 2283-2294.
126. Xin H-W, Wu X-C, Li Q, Yu A-R, Zhong M-Y, Liu Y-Y. 2006. The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers. Methods Find Exp Clin Pharmacol 28: 25-29.
127. Xin HW, Wu XC, Li Q et al. 2002. Effects of coadministration of berberine chloride with cyclosporin on liver microsomal cytochrome P450 isoenzyme and mdr1 in rats. Chin Pharmacol Bull 18: 397-401.
128. Xu XY, Malave A. 2001. Protective effect of berberine on cyclophosphamide-induced haemorrhagic cystitis in rats. Pharmacol Toxicol 88: 232-237.
129. Xu SZ, Zhang Y, Ren JY, Zhou ZN. 1997. Effects of berberine of L- and T-type calcium channels in guinea pig ventricular myocytes. Zhongguo Yao Li Xue Bao 18: 515-518.
130. Yang J, Zhou ZY, Xu JG. 2004. Protective effect of berberine on cardiac hypertrophy induced by L-thyroxine in rats. Sichuan Da Xue Xue Bao Yi Xue Ban 35: 223-225.
131. Yasukawa K, Takido M, Ikekawa T, Shimada F, Takeuchi M, Nakagawa S. 1991. Relative inhibitory activity of berberine-type alkaloids against 12-0-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Chem Pharm Bull 39: 1462-1465.
132. Yeşilada E, Küpeli E. 2002. Berberis crataegina DC. root exhibits potent anti-inflammatory, analgesic and febri-fuge effects in mice and rats. J Ethnopharmacol 79: 237-248.
133. Yin J, Hu R, Chen M et al. 2002. Effects of berberine on glucose metabolism in vitro. Metabolism 51: 1439-1443.
134. Yokozawa T, Ishida A, Kashiwada Y, Cho EJ, Kim HY, Ikeshiro Y. 2004. Coptidis Rhizoma: protective effects against peroxynitrite-induced oxidative damage and elucidation of its active components. J Pharm Pharmacol 56: 547-556.
135. Yount G, Qian Y, Moore D et al. 2004. Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro. J Exp Ther Oncol 4: 137-143.
136. Yuan J, Shen XZ, Zhu XS. 1994. Effect of berberine on transit time of human small intestine. Zhongguo Zhong Xi Yi Jie He Za Zhi 14: 718-720.
137. Zeng XH, Li YY. 2001. Clinical observations of the effect of berberine for congestive heart failure. US Chin J Angiocardiomyopathy 6: 308-311.
138. Zeng XH, Zeng XJ, Li YY. 2003. Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92: 173-176.
139. Zhang W, Chen SG, Ju HS et al. 1992. Mechanisms of protective effects of berbamine on ischemia/reperfusion injury in isolated rat heart. Methods Find Exp Clin Pharmacol 14: 677-684.
140. Zhang RX, Dougherty DV, Rosenblum ML. 1990. Laboratory studies of berberine used alone and in combination with 1,3-bis(2- chloroethyl)-1- nitrosourea to treat malignant brain tumors. Chin Med J 103: 658-665.
141. Zheng L, Zhou Z, Tao D, Lan T. 2003. Protective effect of berberine on cardiac myocyte injured by ischemia-reperfusion. Sichuan Da Xue Xue Bao Yi Xue Ban 34: 452-454.
142. Zhou H, Mineshita S. 2000. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J Pharmacol Exp Ther 294: 822-829.
143. Zhou Z, Sun A, Xu J, Lan T. 2002. Effect of energy preservation of berberine on isolated perfuse heart. Hua Xi Yi Ke Da Xue Xue Bao 33: 431-433.
144. Zhou Z, Xu J, Lan T. 2001. Protective effect of berberine on isolated perfused heart in heart failure. Hua Xi Yi Ke Da Xue Xue Bao 32: 417-418.